Home LiteratureArticle Details
PMID: 16284220 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects.

Thorax ·Vol. 61 ·No. 1 ·2006-01-00 ·Pages 10-6

Yende S, Waterer GW, Tolley EA, Newman AB, Bauer DC, Taaffe DR, Jensen R, Crapo R, Rubin S, Nevitt M, Simonsick EM, Satterfield S, Harris T, Kritchevsky SB

Abstract

Inflammatory markers are increased in chronic obstructive pulmonary disease (COPD) and are hypothesised to play an important part in muscle dysfunction and exercise intolerance. The Health Aging and Body Composition (Health ABC) study is a prospective observational cohort of well functioning individuals aged 70-79 years. A cross sectional analysis of the baseline data was conducted to examine the association between inflammatory markers and ventilatory limitation, muscle strength, and exercise capacity. These associations were compared in participants with and without obstructive lung disease (OLD). Of the 3075 participants enrolled in the Health ABC cohort, OLD was identified by spirometric testing in 268 participants and 2005 participants had normal spirometric results. Of the participants with OLD, 35%, 38%, and 27% participants had mild, moderate, and severe OLD, respectively. Participants with OLD had lower quadriceps strength (102.5 Nm v 108.9 Nm, p = 0.02), lower maximum inspiratory pressure (64.7 cm H(2)O v 74.2 cm H(2)O, p<0.0001), higher systemic interleukin (IL)-6 levels (2.6 pg/ml v 2.2 pg/ml, p<0.0001), and higher C-reactive protein (CRP) levels (3.5 mg/l v 2.5 mg/l, p<0.0001) than those with normal spirometry. In participants with OLD and those with normal spirometry, forced expiratory volume in 1 second (FEV(1)) was associated with IL-6 (adjusted regression coefficients (beta) = -5.3 (95% CI -9.1 to-1.5) and -3.1 (95% CI -4.3 to -1.9), respectively). IL-6 and TNF were also associated with quadriceps strength among participants with OLD and those with normal spirometry (beta = -6.4 (95% CI -12.8 to -0.03) and -3.4 (95% CI -5.4 to -1.3), respectively, for IL-6 and beta = -10.1 (95% CI -18.7 to -1.5) and -3.8 (95% CI -7 to -0.6), respectively, for TNF). IL-6, quadriceps strength, and maximum inspiratory pressures were independent predictors of reduced exercise capacity in both groups. In well functioning elderly subjects with or without OLD, IL-6 is associated with reduced FEV(1), quadriceps strength, and exercise capacity.

MeSH Terms
Aged C-Reactive Protein/metabolism Cross-Sectional Studies Exercise Tolerance/physiology Female Forced Expiratory Volume/physiology Humans Inflammation/metabolism,physiopathology Interleukin-6/metabolism Male Muscle Weakness/metabolism,physiopathology Muscle, Skeletal/metabolism,physiopathology Prospective Studies Pulmonary Disease, Chronic Obstructive/metabolism,physiopathology Regression Analysis Tumor Necrosis Factor-alpha/metabolism Walking/physiology
Chemicals
Interleukin-6 Tumor Necrosis Factor-alpha C-Reactive Protein
Authors & Affiliations
14 authors, click to expand affiliations / ORCID
Yende S
CRISMA Laboratory (Clinical Research, Investigation, and Systems Modeling of Acute Illness), Department of Critical Care Medicine, University of Pittsburgh, PA 15238, USA. [email protected]
Waterer G W
Tolley E A
Newman A B
Bauer D C
Taaffe D R
Jensen R
Crapo R
Rubin S
Nevitt M
Simonsick E M
Satterfield S
Harris T
Kritchevsky S B
References (36)
36 references, click to expand
  1. Peripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanisms.
    Am J Respir Crit Care Med. 2001 Nov 1;164(9):1712-7 PMID: 11719314
  2. Inflammatory response and body composition in chronic obstructive pulmonary disease.
    Am J Respir Crit Care Med. 2001 Oct 15;164(8 Pt 1):1414-8 PMID: 11704588
  3. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study.
    J Gerontol A Biol Sci Med Sci. 2002 May;57(5):M326-32 PMID: 11983728
  4. Leg muscle mass and composition in relation to lower extremity performance in men and women aged 70 to 79: the health, aging and body composition study.
    J Am Geriatr Soc. 2002 May;50(5):897-904 PMID: 12028178
  5. Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments.
    Am J Respir Crit Care Med. 2002 Aug 15;166(4):479-84 PMID: 12186824
  6. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum.
    Am J Respir Crit Care Med. 2002 Nov 1;166(9):1218-24 PMID: 12403691
  7. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins.
    Circulation. 2002 Nov 12;106(20):2555-60 PMID: 12427651
  8. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study.
    Thorax. 2003 May;58(5):388-93 PMID: 12728157
  9. Muscle strength and exercise kinetics in COPD patients with a normal fat-free mass index are comparable to control subjects.
    Chest. 2003 Jul;124(1):75-82 PMID: 12853505
  10. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I.
    Thorax. 2003 Sep;58(9):752-6 PMID: 12947130
  11. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.
    Cell. 2004 Apr 30;117(3):399-412 PMID: 15109499
  12. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis.
    Thorax. 2004 Jul;59(7):574-80 PMID: 15223864
  13. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products.
    J Clin Invest. 2004 Aug;114(3):370-8 PMID: 15286803
  14. Physiologic similarities and differences between COPD and asthma.
    Chest. 2004 Aug;126(2 Suppl):117S-124S; discussion 159S-161S PMID: 15302772
  15. Lung function and risk of myocardial infarction and sudden cardiac death.
    N Engl J Med. 1976 May 13;294(20):1071-5 PMID: 1256523
  16. Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes.
    Biochim Biophys Acta. 1991 Feb 19;1091(3):405-8 PMID: 2001421
  17. The roles of inflammatory cells in the pathogenesis of asthma and of chronic obstructive pulmonary disease.
    Am Rev Respir Dis. 1991 May;143(5 Pt 1):1165-8; discussion 1175-6 PMID: 2024830
  18. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.
    Am Rev Respir Dis. 1991 Nov;144(5):1202-18 PMID: 1952453
  19. Relationship of TNF to interleukins.
    Immunol Ser. 1992;56:499-566 PMID: 1550874
  20. Smoking, pulmonary function, and mortality.
    Ann Epidemiol. 1990 Oct;1(1):25-32 PMID: 1669487
  21. Rapid decline in FEV1. A new risk factor for coronary heart disease mortality.
    Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):390-8 PMID: 7842197
  22. Standardization of Spirometry, 1994 Update. American Thoracic Society.
    Am J Respir Crit Care Med. 1995 Sep;152(3):1107-36 PMID: 7663792
  23. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders.
    Am J Respir Crit Care Med. 1995 Dec;152(6 Pt 1):2021-31 PMID: 8520771
  24. Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients.
    Am J Respir Crit Care Med. 1996 Feb;153(2):633-7 PMID: 8564110
  25. The tumor necrosis factor ligand and receptor families.
    N Engl J Med. 1996 Jun 27;334(26):1717-25 PMID: 8637518
  26. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications.
    Clin Chem. 1997 Jan;43(1):52-8 PMID: 8990222
  27. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease.
    Am J Respir Crit Care Med. 1998 Aug;158(2):629-34 PMID: 9700144
  28. Spirometric reference values from a sample of the general U.S. population.
    Am J Respir Crit Care Med. 1999 Jan;159(1):179-87 PMID: 9872837
  29. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society.
    Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 2):S1-40 PMID: 10194189
  30. Effects of leisure-time physical activity and ventilatory function on risk for stroke in men: the Reykjavík Study.
    Ann Intern Med. 1999 Jun 15;130(12):987-90 PMID: 10383369
  31. Cachexia in cancer--zeroing in on myosin.
    N Engl J Med. 2004 Nov 11;351(20):2124-5 PMID: 15537911
  32. Measuring fitness in healthy older adults: the Health ABC Long Distance Corridor Walk.
    J Am Geriatr Soc. 2001 Nov;49(11):1544-8 PMID: 11890597
  33. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease.
    Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1179-84 PMID: 10764309
  34. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.
    J Clin Endocrinol Metab. 2001 Mar;86(3):1154-9 PMID: 11238501
  35. Cytokines and oxidative signalling in skeletal muscle.
    Acta Physiol Scand. 2001 Mar;171(3):225-32 PMID: 11412134
  36. Role of inflammatory biomarkers in prediction of coronary heart disease.
    Lancet. 2001 Sep 22;358(9286):946-8 PMID: 11583743
Article Info
Journal
Thorax
Abbr.
Thorax
ISSN
0040-6376
Published
2006-01-00
Epub
2005-00-11
Pages
10-6
Language
English
Region
England
NLM ID
0417353
PMCID
PMC2080698
Subset
IM
Grants
NIA NIH HHS · N01-AG-6-2101 · United States
NIA NIH HHS · N01-AG-6-2103 · United States
NIA NIH HHS · N01-AG-6-2106 · United States
NHLBI NIH HHS · R01-HL-074104 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]